FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Aasaan Loans IPO and Emcure Pharma IPO.
Aasaan Loans IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Emcure Pharma IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Aasaan Loans IPO | Emcure Pharma IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Gretex Corporate Services Limited | Kotak Mahindra Capital Company Limited Axis Capital Limited J.P. Morgan India Private Limited Jefferies India Private Limited |
Registrar | Bigshare Services Pvt Ltd | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Aasaan Loans IPO is up to ₹132.00 Cr whereas the issue size of the Emcure Pharma IPO is up to ₹1,952.03 Cr. The final issue price of Aasaan Loans IPO is ₹120.00 per share and of Emcure Pharma IPO is ₹1,008.00 per share.
Aasaan Loans IPO | Emcure Pharma IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹114.00 per share | ₹960.00 per share |
Issue Price (Upper) | ₹120.00 per share | ₹1,008.00 per share |
Issue Price (Final) | ₹120.00 per share | ₹1,008.00 per share |
Discount (Retail) | ||
Discount (Employee) | ₹90.00 per share | |
Market Lot Size | 125 shares | 14 shares |
Fresh Issue Size | 1,10,00,000 shares | 79,36,507 shares |
Fresh Issue Size (Amount) | up to ₹132.00 Cr | up to ₹800.00 Cr |
OFS Issue Size | 1,14,28,839 shares | |
OFS Issue Size (Amount) | up to ₹1,152.03 Cr | |
Issue Size Total | 1,10,00,000 shares | 1,93,65,346 shares |
Issue Size Total (Amount) | up to ₹132.00 Cr | up to ₹1,952.03 Cr |
Aasaan Loans IPO opens on Jun 19, 2024, while Emcure Pharma IPO opens on Jul 03, 2024. The closing date of Aasaan Loans IPO and Emcure Pharma IPO is Jun 21, 2024, and Jul 05, 2024, respectively.
Aasaan Loans IPO | Emcure Pharma IPO | |
---|---|---|
Anchor Bid Date | Jun 18, 2024 | Jul 02, 2024 |
Issue Open | Jun 19, 2024 | Jul 03, 2024 |
Issue Close | Jun 21, 2024 | Jul 05, 2024 |
Basis Of Allotment (Tentative) | Jun 24, 2024 | Jul 08, 2024 |
Initiation of Refunds (Tentative) | Jun 25, 2024 | Jul 09, 2024 |
Credit of Share (Tentative) | Jun 25, 2024 | Jul 09, 2024 |
Listing date (Tentative) | Jun 26, 2024 | Jul 10, 2024 |
Anchor Lockin End date 1 | Jul 24, 2024 | Aug 07, 2024 |
Anchor Lockin End date 2 | Sep 22, 2024 | Oct 06, 2024 |
Aasaan Loans IPO P/E ratio is , as compared to Emcure Pharma IPO P/E ratio of 34.55.
Aasaan Loans IPO | Emcure Pharma IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Akme Fintrade India Ltd Financial Information (Restated)Akme Fintrade India Ltd's revenue increased by 3.06% and profit after tax (PAT) rose by 283.5% between the financial year ending with March 31, 2023 and March 31, 2022.
|
Emcure Pharmaceuticals Limited Financial Information (Restated Consolidated)Emcure Pharmaceuticals Limited's revenue increased by 11.33% and profit after tax (PAT) dropped by -6.1% between the financial year ending with March 31, 2024 and March 31, 2023.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 56.01% | 98.90% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 78.24% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 34.55 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹19029.89 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 5.64%% | 16.90%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 19.37%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 2.49 | 0.67 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹3.87 | ₹29.17 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 5.81%% | 16.87%% |
In the Aasaan Loans IPO retail investors (RII) are offered 36,57,500 shares while in Emcure Pharma IPO retail investors are offered 36,57,500 shares. Qualified institutional buyers (QIB) are offered 20,90,000 shares in Aasaan Loans IPO and 38,53,234 shares in Emcure Pharma IPO.
Aasaan Loans IPO | Emcure Pharma IPO | |
---|---|---|
Anchor Investor Reserveration | 31,35,000 shares | 57,79,850 shares |
Market Maker Reserveration | ||
QIB | 20,90,000 shares | 38,53,234 shares |
NII | 15,67,500 shares | 28,89,926 shares |
RII | 36,57,500 shares | 67,43,160 shares |
Employee | 5,50,000 shares | 1,08,900 shares |
Others | ||
Total | 78,65,000 shares | 1,37,03,538 shares |
Aasaan Loans IPO subscribed 54.49x in total, whereas Emcure Pharma IPO subscribed 67.87x.
Aasaan Loans IPO | Emcure Pharma IPO | |
---|---|---|
QIB (times) | 28.12x | 191.24x |
NII (times) | 129.98x | 49.32x |
Big NII (times) | 121.56x | 54.90x |
Small NII (times) | 146.83x | 38.16x |
RII (times) | 44.58x | 7.36x |
Employee (times) | 5.42x | 8.81x |
Other (times) | ||
Total (times) | 54.49x | 67.87x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|